Clinical Efficacy Trial of Mexiletine for Myotonic Dystrophy Type 1
NCT01406873
·
clinicaltrials.gov ↗
PHASE2
Phase
COMPLETED
Status
42
Enrollment
OTHER
Sponsor class
Conditions
Myotonic Dystrophy
Interventions
DRUG:
Mexiletine
DRUG:
Placebo
Sponsor
University of Rochester